Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease

Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation

(2012) Jordan E. Axelrad et al.   Clinical Gastroenterology and Hepatology

Immunosuppression in Patients with Crohn’s Disease and Neoplasia

(2012) Bobby V. M. Dasari et al.   DISEASES OF THE COLON & RECTUM

Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease

(2012) Millie D. Long et al.   GASTROENTEROLOGY

Factors affecting outcomes in Crohn's disease over 15 years

(2012) Jacques Cosnes et al.   GUT

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents

(2011) Pauline Raaschou et al.   ARTHRITIS AND RHEUMATISM

TNF inhibitor suppresses bone metastasis in a breast cancer cell line

(2011) Takahiko Hamaguchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer

(2011) Matthew S. Wosnitzer et al.   CANCER

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

(2011) Laurent Peyrin–Biroulet et al.   GASTROENTEROLOGY

Epidemiology and Natural History of Inflammatory Bowel Diseases

(2011) Jacques Cosnes et al.   GASTROENTEROLOGY

Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?

(2011) Laurent Beaugerie   GUT

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent

(2011) Jacques Tortochaux et al.   RADIOTHERAPY AND ONCOLOGY

Effects of Chronic Immunosuppression on Long-term Oncologic Outcomes for Colorectal Cancer Patients Undergoing Surgery

(2010) Wisam Khoury et al.   ANNALS OF SURGERY

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma

(2010) J M G Larkin et al.   BRITISH JOURNAL OF CANCER

Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden

(2010) Xiaochen Shu et al.   INFLAMMATORY BOWEL DISEASES

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

(2009) Aminah Jatoi et al.   LUNG CANCER

Cancer risks in Crohn disease patients

(2008) K. Hemminki et al.   ANNALS OF ONCOLOGY

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

(2008) C Salliot et al.   ANNALS OF THE RHEUMATIC DISEASES

Fatigue in patients with advanced cancer: a pilot study of an intervention with infliximab

(2008) A. J. Tookman et al.   SUPPORTIVE CARE IN CANCER

Survival in Danish patients with breast cancer and inflammatory bowel disease: A nationwide cohort study

(2007) Kirstine Kobbere Sgaard et al.   INFLAMMATORY BOWEL DISEASES